ロード中...
Chemoprevention of Murine Lung Cancer by Gefitinib in Combination with Prostacyclin Synthase Overexpression
INTRODUCTION: We hypothesized that the combination of the EGFR tyrosine kinase inhibitor (TKI) gefitinib with the powerful chemopreventive manipulation of lung specific transgenic prostacyclin synthase (PGIS) overexpression on tumorigenesis in FVB/N mice would result in augmented chemoprevention. MA...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3098617/ https://ncbi.nlm.nih.gov/pubmed/20116128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2010.01.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|